$BV

BrightView Holdings, Inc.

No enriched coverage for $BV in the last 7 days.

No SEC Form 4 filings for $BV in the last 30 days.

Med

BrightView Holdings' (NYSE:BV) Solid Earnings Have Been Accounted For Conservatively

BrightView Holdings' recent earnings report pleased investors, with a deeper look revealing several encouraging factors. The company's statutory profit was reduced by US$21m due to unusual items, which are often non-recurring, suggesting potential profit increase in the future. Despite losing money last year, BrightView Holdings made a profit this year, indicating conservative accounting and stronger underlying earnings potential.

BrightView Holdings (BV) Q2 Earnings and Revenues Surpass Estimates

BrightView Holdings (BV) reported Q2 earnings of $0.09 per share, exceeding the Zacks Consensus Estimate of $0.08, despite a decrease from $0.14 a year ago. The company's revenues for the quarter reached $702.9 million, surpassing the estimate by 9.06% and increasing from $662.6 million in the prior year. Despite recent stock underperformance, its Zacks Rank #3 (Hold) suggests it will perform in line with the market.

BrightView posts revenue gain as losses widen in Q1

BrightView Holdings reported a revenue increase but also a widening of losses in its first quarter results. The company's financial performance shows top-line growth while grappling with deeper net losses during the period.